Irhythm Holdings, Inc. current report, 17 July 2017

Full document

Business Context and Reporting Period

This Form 8-K filing by iRhythm Technologies, Inc. (now iRhythm Holdings, Inc.) covers the date of July 17, 2017. The report details corporate governance changes, specifically the election of new directors and their appointment to board committees.

Key Financial Metrics

The filing does not provide financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on personnel and governance matters.

Material Changes

  • Board Elections: Bruce G. Bodaken and Ralph Snyderman were elected to the Board of Directors, effective July 17, 2017.
  • Committee Appointments: Mr. Bodaken was appointed Chairman of the Compensation Committee, and Dr. Snyderman was appointed to the Audit Committee.
  • Director Terms: Both directors serve in the class expiring at the 2019 annual meeting of stockholders.

Guidance, Outlook, and Compensation

The filing contains no financial guidance, outlook, or management commentary regarding business operations. However, it discloses specific compensatory arrangements for the new directors:

  • Stock Options: Each director received an option to purchase 4,089 shares, vesting monthly over 36 months.
  • Restricted Stock Units (RSUs): Each director received RSUs covering 1,949 shares, vesting annually over three years.
  • Standard Compensation: Both directors will participate in the standard non-employee director compensation program.

Investor Verification Checklist

  • Verify the professional backgrounds of Bruce G. Bodaken (former Blue Shield of California CEO) and Ralph Snyderman (former Duke University Health System CEO) to assess their strategic fit.
  • Review the Company's 2016 Equity Incentive Plan terms referenced in the filing for full details on the vesting schedules.
  • Check the Definitive Proxy Statement filed on April 27, 2017, for the complete structure of the non-employee director compensation program.
  • Confirm the press release dated July 19, 2017 (Exhibit 99.1) for any additional public statements regarding these appointments.